| 000 | 01899 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516044820.0 | ||
| 264 | 0 | _c20120515 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.2011.01585.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFretellier, N | |
| 245 | 0 | 0 |
_aHyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cFeb 2012 |
||
| 300 |
_a1151-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aContrast Media _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFemur _xmetabolism |
| 650 | 0 | 4 |
_aGadolinium _xblood |
| 650 | 0 | 4 |
_aGadolinium DTPA _xadverse effects |
| 650 | 0 | 4 |
_aHyperphosphatemia _xblood |
| 650 | 0 | 4 |
_aLiver _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNephrogenic Fibrosing Dermopathy _xblood |
| 650 | 0 | 4 |
_aProcollagen-Proline Dioxygenase _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRenal Insufficiency _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xmetabolism |
| 700 | 1 | _aIdée, Jm | |
| 700 | 1 | _aBruneval, P | |
| 700 | 1 | _aGuerret, S | |
| 700 | 1 | _aDaubiné, F | |
| 700 | 1 | _aJestin, G | |
| 700 | 1 | _aFactor, C | |
| 700 | 1 | _aPoveda, N | |
| 700 | 1 | _aDencausse, A | |
| 700 | 1 | _aMassicot, F | |
| 700 | 1 | _aLaprévote, O | |
| 700 | 1 | _aMandet, C | |
| 700 | 1 | _aBouzian, N | |
| 700 | 1 | _aPort, M | |
| 700 | 1 | _aCorot, C | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 165 _gno. 4b _gp. 1151-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2011.01585.x _zAvailable from publisher's website |
| 999 |
_c20992546 _d20992546 |
||